The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2025 | The evolving roles of radiotherapy in managing mesothelioma
Crispin Hiley, MBChB, PhD, University College London, London, UK, discusses the various roles of radiation therapy in mesothelioma treatment, including palliative radiotherapy and stereotactic radiotherapy for patients with limited progression. Dr Hiley additionally comments on the promising results of the HIT-Meso trial (NCT05655078). This interview took place at 2025 World Conference on Lung Cancer (WCLC) in Barcelona, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Transcript
So I was very grateful to be invited by iMig to talk about radiation from mesothelioma and that was a talk really to talk about the wide-ranging role of radiation therapy for patients with that disease and so I talked about palliative radiotherapy which is probably one of the most common uses but also the evolving use of stereotactic radiotherapy for patients with limited progression in mesothelioma and then also about a trial we have in the UK called HIT-Meso which is looking at hemithoracic radiotherapy with proton beam radiotherapy...
So I was very grateful to be invited by iMig to talk about radiation from mesothelioma and that was a talk really to talk about the wide-ranging role of radiation therapy for patients with that disease and so I talked about palliative radiotherapy which is probably one of the most common uses but also the evolving use of stereotactic radiotherapy for patients with limited progression in mesothelioma and then also about a trial we have in the UK called HIT-Meso which is looking at hemithoracic radiotherapy with proton beam radiotherapy. It’s a randomized study supported by Asthma and Lung UK and NHS England.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
Read more...
